| Literature DB >> 28505125 |
Nahed O Bawakid1, Walied M Alarif2, Najla A Alburae3, Hajer S Alorfi4, Khalid O Al-Footy5, Sultan S Al-Lihaibi6, Mohamed A Ghandourah7.
Abstract
Chromatographic fractionation of the CH₂Cl₂/MeOH extract of the Red Sea red alga Laurencia obtusa gave two new hexahydrofuro[3,2-b]furan-based C15-acetogenins, namely, isolaurenidificin (1) and bromlaurenidificin (2). The chemical structures were elucidated based on extensive analyses of their spectral data. Compounds 1 and 2 showed no toxicity (LC50 > 12 mM) using Artemia salina as test organism. Both compounds showed weak cytotoxicity against A549, HepG-2, HCT116, MCF-7, and PC-3 cells, however, they exhibited a relatively potent cytotoxic activity against peripheral blood neutrophils. This can be attributed partly to induction of apoptosis.Entities:
Keywords: anti-inflammatory; fatty acids; halogenations; marine algae; spectroscopy
Mesh:
Substances:
Year: 2017 PMID: 28505125 PMCID: PMC6154321 DOI: 10.3390/molecules22050807
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Selected COSY () and HMBC () correlations of 1 and 2.
Figure 2Chemical structures of compounds 1–3.
Figure 3Induction of apoptosis by compounds 1 and 2 in peripheral blood neutrophils (A); A549 lung carcinoma cells (B); HepG2 hepatocellular carcinoma cells (C); HCT116 colorectal carcinoma cells (D); MCF-7 Breast cancer cells (E) and PC-3 prostate cancer cells (F). Each compound was used at a concentration of 50 mM/L.
The cytotoxic activity (IC50) values of 1 and 2 against human cancer cells. *
| Compound | |||||
|---|---|---|---|---|---|
| A 549 | HepG2 | HCT116 | MCF-7 | PC-3 | |
| 15.6 | 15.1 | >20 | 15.5 | 17.9 | |
| 15.9 | 15.3 | 17.9 | 17.9 | >20 | |
* A549 (lung carcinoma cells); HepG2 (hepatocellular carcinoma cells; HCT116 (colorectal carcinoma cells); MCF-7 (Breast cancer cells) and PC-3 (prostate cancer cells). All cells were incubated with compounds 1 or 2 for 72 h.
Effect of the isolated compounds on apoptosis of peripheral blood neutrophils. *
| Compound | % Apoptotic Neutrophils (Mean ± S.D.) | |||
|---|---|---|---|---|
| 0 h | 24 h | 48 h | 72 h | |
| (Control) | 0.41 ± 0.01 | 0.41 ± 0.01 | 0.41 ± 0.01 | 0.41 ± 0.01 |
|
| 0.63 ± 0.55 | 30.10 ± 3.11 | 44.86 ± 3.59 | 59.45 ± 3.76 |
|
| 0.80 ± 0.56 | 27.91 ± 2.93 | 53.62 ± 2.01 | 70.13 ± 2.51 |
* Neutrophils were incubated with compounds 1 or 2 for the assigned time.
1H- and 13C-NMR spectral data for compounds 1 a and 2 b.
| Position | 1 | 2 | ||||
|---|---|---|---|---|---|---|
| δH | Mult. | δC | δH | Mult. | δC | |
| 1 | 3.15 | d, | 82.8 | 2.76 | d, | 82.8 |
| 2 | - | 79.9 | - | 79.8 | ||
| 3 | 5.63 | ddd, | 111 | 5.35 | ddd, | 110.6 |
| 4 | 6.18 | ddd, | 141.1 | 5.85 | ddd, | 141.4 |
| 5 | 2.9 | m | 35.5 | 2.83 | m | 35.4 |
| 2.96 | dddd, | 2.87 | m | |||
| 6 | 4.15 | ddd, | 55.7 | 3.83 | m | 55 |
| 7 | 4.08 | dd, | 83.6 | 3.56 | ddd, | 82.7 |
| 8 | 2.02 | m | 36.8 | 1.66 | ddd, | 36.9 |
| 2.32 | ddd, | 1.85 | ddd, | |||
| 9 | 4.55 | ddd, | 84.3 | 3.99 | ddd, | 84.9 |
| 10 | 4.53 | ddd, | 85 | 3.82 | m | 84.1 |
| 11 | 2.02 | m | 34.9 | 1.91 | ddd, | 37.5 |
| 2.22 | ddd, | 2.28 | dd, | |||
| 12 | 3.88 | ddd, | 84.3 | 3.93 | ddd, | 83.6 |
| 13 | 3.54 | ddd, | 75.2 | 4.24 | ddd, | 61.4 |
| 14 | 1.51 | m | 26.5 | 1.76 | ddq, | 28.4 |
| 1.45 | m | 2.15 | dddd, | |||
| 15 | 1 | t, | 10.1 | 1.04 | t, | 11.2 |
a 1 was measured in CDCl3; b 2 was measured in C6D6.